v3.25.3
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
Sep. 30, 2025
Dec. 31, 2024
Current assets    
Cash $ 299,938 $ 155,647
Accounts receivable, net of allowance for credit losses of $9,018 and $13,400 as of September 30, 2025 and December 31, 2024, respectively 57,049 6,966
Note receivable 3,500,000
Other receivable 152,000
Equity investment 466,500
Inventories 174,189 212,494
Prepaid expenses and other 572,797 33,830
Deferred offering costs 31,755
Interest receivable 36,888
Total current assets 1,287,728 4,412,325
Fixed assets, net    
Computer equipment, net 5,347
Goodwill 97,165,375
Total assets 98,458,450 4,412,325
Current liabilities    
Accounts payable 7,951,334 1,108,777
Accrued compensation 383,093
Accrued creator commissions 2,506,631
Settlement payable 341,875 484,735
Accrued expenses 2,537,340 596,610
Accrued expenses - related parties 309,333 309,333
Accrued sales tax 2,144,860
Deferred revenue 2,829,854 1,919
Financing arrangement, net of discount 172,158
Convertible notes payable, net of discount 5,704,540 432,105
Notes payable, current portion, net of discount 2,397,091
Total current liabilities 27,278,109 2,933,479
Total liabilities 27,278,109 2,933,479
Series A preferred stock, $0.001 par value – 10,000 shares authorized at September 30, 2025 and December 31, 2024; 4,500 and 9,350 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively, preference in liquidation of $852,567 and $1,597,706 at September 30, 2025 and December 31, 2024, respectively 5 9
Series B preferred stock, $0.001 par value – 50,000 shares authorized at September 30, 2025 and December 31, 2024; 5,250 and 50,000 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively, preference in liquidation of $787,500 and $7,500,000 at September 30, 2025 and December 31, 2024, respectively 5 50
Series C preferred stock, $0.001 par value – 100,000 and 0 shares authorized at September 30, 2025 and December 31, 2024, respectively; 8,550 and 0 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively; preference in liquidation of $855,000 and $0 at September 30, 2025 and December 31, 2024, respectively 9
Series D preferred stock, $0.001 par value – 750,000 and 0 shares authorized at September 30, 2025 and December 31, 2024; 0 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively; preference in liquidation of $0 at September 30, 2025 and December 31, 2024
Common stock, $0.001 par value - 100,000,000 shares authorized at September 30, 2025 and December 31, 2024; 6,410,742 and 726,670 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively 6,413 727
Additional Paid-In Capital 112,757,076 30,636,861
Accumulated deficit (41,583,167) (29,158,801)
Total stockholders’ equity 71,180,341 1,478,846
Total liabilities and stockholders’ equity $ 98,458,450 $ 4,412,325

Source